Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms
- 25 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (5), 2659-2668
- https://doi.org/10.1021/acs.jmedchem.0c01779
Abstract
The ligand-activated transcription factor nuclear receptor related-1 (Nurr1) exhibits great potential for neurodegenerative disease treatment, but potent Nurr1 modulators to further probe and validate the nuclear receptor as a therapeutic target are lacking. We have systematically studied the structure–activity relationship of the 4-amino-7-chloroquinoline scaffold contained in Nurr1 activators amodiaquine and chloroquine and discovered fragment-like analogues that activated Nurr1 in several cellular settings. The most active descendants promoted the transcriptional activity of Nurr1 on human response elements as monomer, homodimer, and heterodimer and markedly enhanced Nurr1-dependent gene expression in human astrocytes. As a tool to elucidate mechanisms involving in Nurr1 activation, these Nurr1 agonists induced robust recruitment of NCoR1 and NCoR2 co-regulators to the Nurr1 ligand binding domain and promoted Nurr1 dimerization. These findings provide important insights in Nurr1 regulation. The fragment-sized Nurr1 agonists are appealing starting points for medicinal chemistry and valuable early Nurr1 agonist tools for pharmacology and chemical biology.Keywords
Funding Information
- Aventis Foundation
- LOEWE center Translational Medicine and Pharmacology, Goethe University Frankfurt am Main
This publication has 24 references indexed in Scilit:
- Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor AgonistJournal of Medicinal Chemistry, 2014
- The role of ligand efficiency metrics in drug discoveryNature Reviews Drug Discovery, 2014
- NURR1 in Parkinson disease—from pathogenesis to therapeutic potentialNature Reviews Neurology, 2013
- Discovery and Characterization of Novel, Potent, and Selective Cytochrome P450 2J2 InhibitorsDrug Metabolism and Disposition, 2012
- Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquineBioorganic & Medicinal Chemistry Letters, 2012
- In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2)Bioorganic & Medicinal Chemistry Letters, 2010
- Candidate Selection and Preclinical Evaluation of N-tert-Butyl Isoquine (GSK369796), An Affordable and Effective 4-Aminoquinoline Antimalarial for the 21st CenturyJournal of Medicinal Chemistry, 2009
- Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptorsNature, 2003
- Amodiaquine-induced fulminant hepatitisJournal of Hepatology, 1988
- GAL4-VP16 is an unusually potent transcriptional activatorNature, 1988